Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Raffeld

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Human Pathology|March 1, 1997
Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlationsA Mansoor, M S Stevenson, R Z Li, et al.
Blood|April 15, 1996
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomasL Hernandez, T Fest, M Cazorla, et al.
The Journal of Pathology|September 19, 2006
Evolution of VHL tumourigenesis in nerve root tissueA O Vortmeyer, M G B Tran, W Zeng, et al.
The American Journal of Pathology|November 12, 1998
Pathological findings in human autoimmune lymphoproliferative syndromeM S Lim, S E Straus, J K Dale, et al.
Leukemia|April 27, 2013
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapyS E M Herman, X Sun, E M McAuley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2001
ANX7, a candidate tumor suppressor gene for prostate cancerM Srivastava, L Bubendorf, V Srikantan, et al.
Blood|May 9, 2001
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expressionU Lopatin, X Yao, R K Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancerC A Carter, A Rajan, C Keen, et al.
The New England Journal of Medicine|February 24, 2001
Gene-expression profiles in hereditary breast cancerI Hedenfalk, D Duggan, Y Chen, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Human Pathology|March 1, 1997
Prevalence of Epstein-Barr viral sequences and EBV LMP1 oncogene deletions in Burkitt's lymphoma from Pakistan: epidemiological correlationsA Mansoor, M S Stevenson, R Z Li, et al.
Blood|April 15, 1996
p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomasL Hernandez, T Fest, M Cazorla, et al.
The Journal of Pathology|September 19, 2006
Evolution of VHL tumourigenesis in nerve root tissueA O Vortmeyer, M G B Tran, W Zeng, et al.
The American Journal of Pathology|November 12, 1998
Pathological findings in human autoimmune lymphoproliferative syndromeM S Lim, S E Straus, J K Dale, et al.
Leukemia|April 27, 2013
Modeling tumor-host interactions of chronic lymphocytic leukemia in xenografted mice to study tumor biology and evaluate targeted therapyS E M Herman, X Sun, E M McAuley, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 5, 2001
ANX7, a candidate tumor suppressor gene for prostate cancerM Srivastava, L Bubendorf, V Srikantan, et al.
Blood|May 9, 2001
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expressionU Lopatin, X Yao, R K Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 24, 2016
Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancerC A Carter, A Rajan, C Keen, et al.
The New England Journal of Medicine|February 24, 2001
Gene-expression profiles in hereditary breast cancerI Hedenfalk, D Duggan, Y Chen, et al.
International Journal of Cancer|May 20, 2016
Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750-an antisense oligonucleotide against eIF4E-in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancerA G Duffy, O V Makarova-Rusher, S V Ulahannan, et al.
Pageof 17